Cathartic Colon Clinical Trial
Official title:
A Randomized Controlled Study Comparing PicoSalax, Versus PicoSalax and Fleet Enema Versus Fleet Enema Alone for Sigmoidoscopy
Verified date | September 2015 |
Source | Queen's University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Ethics Review Committee |
Study type | Interventional |
Objective and Hypothesis:
The investigators objective is to help determine the efficacy of oral and rectal bowel
preparation regimens for sigmoidoscopy. The investigators hypothesis is that oral
preparation will reduce the amount of repeat rectal enemas required and improve the quality
of a bowel exam at the sigmoidoscopy.
Status | Completed |
Enrollment | 120 |
Est. completion date | September 2015 |
Est. primary completion date | September 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Consecutive male and non-pregnant female patients >18 years old who require outpatient sigmoidoscopy will be considered for inclusion. Exclusion Criteria: - previous colorectal surgery and patients with reduced renal function or other medical conditions that would increase the risk of receiving oral PicoSalx would be excluded from the study. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Canada | Hotel Dieu Hospital | Kingston | Ontario |
Canada | Kingston General Hospital | Kingston | Ontario |
Lead Sponsor | Collaborator |
---|---|
Queen's University |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Quality of colon cleansing | The primary outcomes for this trial will be the quality of colon cleansing in the area of the colon examined. We will use a modified Ottawa bowel preparation scoring system measured at the time of endoscopy | At the time of the flexible sigmoidoscopy, therefore, within 24 hours of flexible sigmoidoscopy | No |
Secondary | Patient tolerance questionnaire | The questionnaire delivered one half hour prior to the sigmoidoscopy will ask the patient about acceptability of the bowel prep, the patient's compliance with the bowel prep, if the patient would have the same bowel preparation regimen again for another sigmoidoscopy. We also will look at side effects including wind, incontinence, sleep disturbance, bottom soreness, abdominal tenderness, and nausea. | At the time of the flexible sigmoidoscopy, therefore, within 24 hours of flexible sigmoidoscopy | Yes |
Secondary | Requirement for an additional rectal enema. | We also will record whether an additional enema was required to complete an adequate examination. | At the time of the flexible sigmoidoscopy, therefore, within 24 hours of flexible sigmoidoscopy | No |
Secondary | Maximum length of scope inserted | The maximum scope length reached during the endoscopic procedure will be recorded. We will also record the type of endoscopic equipment used for the sigmoidoscopy, ie. gastroscope, pediatric colonoscope, sigmoidoscope, etc. | At the time of the flexible sigmoidoscopy, therefore, within 24 hours of flexible sigmoidoscopy | No |
Secondary | Reason for discontinuing further advancement of the scope | The main reason for no further advancement of the sigmoidoscope will be recorded as: inadequate prep, patient intolerance, adequate examination length reached for procedure indication. | At the time of the flexible sigmoidoscopy, therefore, within 24 hours of flexible sigmoidoscopy | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02263443 -
Appropriated Bowel Preparation Before Exploratory Laparotomy in Gynecologic Surgery
|
N/A | |
Completed |
NCT02371655 -
Different Bowel Preparations in CT Colonography: is Diet Necessary? A Randomized Controlled Trial
|
N/A | |
Completed |
NCT06339697 -
Short-term Effects of Bowel Preparation on Gut Microbiome in Patients Undergoing Endoscopic Colon Polypectomy
|
Phase 4 | |
Completed |
NCT02761213 -
Oral Sulfate Solution (SUPREP) Versus Polyethylene Glycol (PEG) Plus Ascorbic Acid
|
Phase 4 |